Indsoya Rights Issue 2025 vs Valiant Laboratories Limited Rights Issue 2025

Comparison between Indsoya Rights Issue 2025 and Valiant Laboratories Limited Rights Issue 2025.

Rights Issue details

Find important information like Listing Exchange, Terms of payment and Entitlement Ratio for Indsoya Rights Issue 2025 and Valiant Laboratories Limited Rights Issue 2025. Indsoya Rights Issue 2025 is listed on BSE while Valiant Laboratories Limited Rights Issue 2025 is listed on BSE, NSE.

 Indsoya LtdValiant Laboratories Limited
LogoIndsoya Rights Issue 2025 LogoValiant Laboratories Limited Rights Issue 2025 Logo
Listing AtBSEBSE, NSE
Terms of Payment

Full amount of Rs.5/- per Equity Share is payable on application.

As per Terms of Payment, The Full amount of the Issue Price, being Rs . 75/- per share, will be payable on Application.

Entitlement25 Rights Equity Share(s) for every 1 fully paid-up Equity Shares held on Record Date1 Rights Equity Share(s) for every 4 fully paid-up Equity Shares held on Record Date
Application FormApplication Form Application Form
Letter of Offer Letter of Offer Letter of Offer
RegistrarMUFG Intime India Pvt.Ltd.MUFG Intime India Pvt.Ltd.
Lead Managers

Rights Issue Size and Price

The issue size of Indsoya Rights Issue 2025 rights issue is ₹5.00 Crores, whereas Valiant Laboratories Limited Rights Issue 2025 rights issue size is ₹81.47 Crores.

 Indsoya LtdValiant Laboratories Limited
Issue Size1,00,00,000 shares1,08,62,500 shares
Issue Size (Amount)₹5.00 Crores₹81.47 Crores
Issue Price₹5 per share₹75 per share
Face Value₹5 per share₹10 per share

Rights Issue Timetable

Find all the important dates related to the rights issue. The record date of Indsoya Rights Issue 2025 is Jul 07, 2025 while record date of Valiant Laboratories Limited Rights Issue 2025 is Jul 19, 2025.

 Indsoya LtdValiant Laboratories Limited
Record DateJul 07, 2025Jul 19, 2025
Credit of Rights EntitlementsJul 15, 2025Jul 21, 2025
Bid/Offer Opens OnJul 16, 2025Jul 28, 2025
Renunciation of Rights EntitlementsJul 23, 2025Aug 05, 2025
Bid/Offer Closes OnJul 29, 2025Aug 08, 2025
Deemed Date of AllotmentAug 04, 2025Aug 11, 2025
Credit DateAug 08, 2025Aug 12, 2025
Listing DateAug 13, 2025Aug 13, 2025

Financials details

Comparison of Indsoya Rights Issue 2025 and Valiant Laboratories Limited Rights Issue 2025 financial data, including total revenue, PAT, and net worth. The table below also includes a list of all relevant documents like the Application Form and Letter of Offer. Related Parties like Lead Manager and Registrar are also mentioned in this section.

 Indsoya LtdValiant Laboratories Limited
Financial

Apollo Ingredients Limited Financial Information (Restated)

Apollo Ingredients Limited's revenue increased by 207% and profit after tax (PAT) rose by 60% between the financial year ending with March 31, 2025 and March 31, 2024.

Period Ended31 Mar 202531 Mar 202431 Mar 202331 Mar 2022
Assets1.671,72,418.501.161.21
Revenue3.081.000.032.49
Profit After Tax0.100.06-0.070.06
Reserves and Surplus0.980.92
Amount in ₹ Crore

Valiant Laboratories Limited Financial Information (Restated Consolidated)

Valiant Laboratories Limited's revenue decreased by 27% and profit after tax (PAT) dropped by 789% between the financial year ending with March 31, 2025 and March 31, 2024.

Period Ended31 Mar 202531 Mar 2024
Revenue133.38182.06
Profit After Tax-2.200.32
Net Worth234.31236.86
Reserves and Surplus190.86193.41
Amount in ₹ Crore

Compare with others

Compare:

Indsoya Rights Issue 2025 Vs Valiant Laboratories Limited Rights Issue 2025